Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Induction Chemotherapy
100%
Neoadjuvant Chemotherapy
100%
Paranasal Sinuses
100%
Advanced Squamous Cell Carcinoma
100%
Oncological Outcomes
37%
Sinonasal Squamous Cell Carcinoma (SNSCC)
37%
Surgical Resection
25%
Partial Response
25%
Disease-free Survival
25%
Organ Preservation
25%
T4 Disease
25%
As(V)
12%
Patient Demographics
12%
Doublet
12%
Adjuvant Therapy
12%
Favorable Outcome
12%
Squamous Cell Carcinoma (SqCC)
12%
Advanced Stage
12%
Surgical Adjuvants
12%
Improved Outcomes
12%
Complete Response
12%
5-fluorouracil (5-FU)
12%
Cetuximab
12%
Recurrence Rate
12%
Most Common Form
12%
Lymph Node Metastasis
12%
Advanced Disease
12%
Curative Intent
12%
Chemotherapy Regimen
12%
Ifosfamide
12%
Locally Advanced
12%
Standard of Care
12%
Squamous Carcinoma
12%
Distant Metastasis
12%
Stable Disease
12%
Presentation Time
12%
University of Texas
12%
Previously Untreated
12%
Sinonasal
12%
Taxanes
12%
Progressive Disease
12%
Residual Disease
12%
Adjuvant Radiation
12%
Local Therapy
12%
Adjuvant Chemoradiation
12%
Staged Treatment
12%
MD Anderson Cancer Center
12%
Definitive Chemoradiation
12%
Definitive Radiation
12%
Tumor Staging
12%
Surgical Salvage
12%
Sinonasal Malignancy
12%
Consecutive Patients
12%
Subsequent Therapy
12%
Medicine and Dentistry
Induction Chemotherapy
100%
Squamous Cell Carcinoma
100%
Neoadjuvant Chemotherapy
100%
Paranasal Sinus
100%
Diseases
62%
Disease Free Survival
25%
Chemoradiotherapy
25%
Malignant Neoplasm
12%
Adjuvant Therapy
12%
Survival Rate
12%
Recurrent Disease
12%
Cancer
12%
Carcinoma
12%
Cetuximab
12%
Lymph Node Metastasis
12%
Recurrence Risk
12%
Fluorouracil
12%
Cancer Staging
12%
Distant Metastasis
12%
Minimal Residual Disease
12%
Local Therapy
12%
Progressive Disease
12%
Chemotherapy
12%
Ifosfamide
12%
Median Follow Up
12%
Platinum
12%